First Light Biosciences is now

First Light Diagnostics

First Light Diagnostics develops innovative diagnostic tests that enable rapid and accurate detection of pathogens that can cause life-threatening infections. Our antimicrobial susceptibility tests will help ensure that patients suffering from infection receive appropriate antibiotic treatment options in hours and not days compared to current practices. Leveraging our highly differentiated MultiPath™ technology, our products strive to save lives, lower healthcare costs, improve antibiotic stewardship, and prevent the spread of antibiotic drug-resistance.

The Causes of Antibiotic Drug Resistance

Watch a recent New York Times video that discusses the history of Antibiotics,  how overuse has created patient risk through ever increasing drug-resistant strains, and why improved use of antibiotics is critical to turning the tide.

Watch Don Straus Discuss the MultiPathTM Technology

What Sets Us Apart?

Our MultiPath technology is advancing the field of rapid diagnostics in several key areas:
Time to Result

Time to Result

Automation

Automation

Versatility

Versatility

The MultiPath technology outperforms current culture-based methods by providing pathogen identification results in 30 minutes and antimicrobial susceptibility test results in 4 hours…directly from patient sample.

The MultiPath analyzer is a fully automated “sample-to-answer” platform. By combining this level of automation with rapid tests, we can perform up to 40 antimicrobial susceptibility tests or 200 identification tests in a single 8-hour shift.

The MultiPath platform is unique in its ability to rapidly identify a broad range of pathogens, detect toxins and biomarkers with high sensitivity, and perform rapid phenotypic antimicrobial susceptibility testing.

Menu